Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Mol Cancer Ther. 2010 Dec;9(12):3105–3114. doi: 10.1158/1535-7163.MCT-10-0674

Table 1.

Drug Activities Across Leukemia and CNS Cell Lines and Summary Statistics for Complete NCI-60 Cell Line Screen

NSC number FdUMP(10) Fluorouracil (5FU) Floxuridine (FUdR) Topotecan HCl Irinotecan HCl
697912 19893 27640 609699 616348
CNS:SF-268 8.30 4.30 6.53 7.92 5.41
CNS:SF-295 8.30 4.30 6.50 7.69 5.14
CNS:SF-539 8.30 5.88 6.53 7.89 5.30
CNS:SNB19 6.77 3.94 5.91 7.66 4.62
CNS:SNB75 6.45 3.74 6.03 7.68 4.80
CNS:U251 6.94 4.35 6.35 7.79 5.39
LE:CCRF-CEM na 4.48 6.41 8.07 5.46
LE:HL-60 7.90 4.68 6.27 7.85 4.95
LE:K-562 5.63 4.68 6.11 7.22 4.96
LE:MOLT-4 8.28 4.87 6.44 8.06 5.78
LE:RPMI-8226 6.64 5.31 5.74 6.61 4.69
LE:SR 8.30 5.38 6.50 7.66 6.63
NCI-60 Minimum 4.30 3.31 3.61 5.45 4.08
NCI-60 Maximum 8.30 5.98 6.58 8.07 6.63
NCI-60 Average 7.15 4.64 5.83 7.19 4.89
NCI-60 Range 4.00 2.67 2.96 2.63 2.55
a

Drug activities are GI50’s, presented as −log10 values.